News
These 3 Stocks Just Got Upgraded—and Could Keep Climbing
Investors watch Wall Street for signals about potential movement in stocks, and an upgrade from analysts is one important marker of shifting fundamentals. Analyst upgrades come in response to a
Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Now that the first quarter of the new year is underway, investors might look for the best potential plays in the stock market. Having the confidence and financial momentum to start the year can
Executive Chairman Sells 35,000 Knight-Swift Transportation Shares for $1.8 Million. Is This a Cue to Something More Ominous?
Kevin P. Knight, Executive Chairman of Knight-Swift Transportation Holdings (NYSE:KNX), reported the indirect open-market sale of 35,000 shares for a transaction value of ~$1.8 million on Dec. 9
Tvardi Posts Q2 Net Income Turnaround
Tvardi Therapeutics (NASDAQ:TVRD), a clinical-stage biopharmaceutical company focused on developing new therapies for serious diseases, released its second quarter fiscal 2025 results on August 14
Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced positive results from a Phase 1 single-ascending-dose (SAD) study of aritinercept (AUR200), its dual inhibitor of B cell-activating
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it will host a webcast and conference call on June 30, 2025, at 8:30 a.m. ET to discuss AUR200 Phase 1 study results. The link to
New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today announced that a post-hoc analysis of the 52-week, Phase 3 AURORA 1 study showed that lupus nephritis (LN) patients who
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three months ended March 31, 2025.
First Quarter 2025 Financial Results
-
Total Revenue: For the three
Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release first quarter 2025 financial and operational results before markets open on May 12, 2025.
Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
Aurinia Pharmaceuticals Inc. (“Aurinia” or the “Company”) (NASDAQ: AUPH) today announced that leading independent proxy advisor Glass, Lewis & Co. LLC (“Glass Lewis”) has recommended that Aurinia
ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
Aurinia Pharmaceuticals Inc. (“Aurinia” or the “Company”) (NASDAQ: AUPH) today announced that leading independent proxy advisor Institutional Shareholder Services (“ISS”) has recommended that
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and twelve months ended December 31, 2024 and provided an update on recent corporate progress.
Fourth
Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release 2024 fourth quarter and full year financial and operational results before markets open on
Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats
LONDON, UK / ACCESS Newswire / November 14, 2025 / Two pioneering studies published in the journal Animals have explored in depth how dog and cat guardians perceive more sustainable pet
Revolution im Bereich Tiernahrung: Zwei neue weltweite Umfragen zeigen wachsende Offenheit der Tierhalter für nachhaltige Ernährung von Hunden und Katzen
London, UK / Access Newswire / 14. November 2025 / Zwei zukunftsweisende in der Fachzeitschrift Animals veröffentlichte Studien haben eingehend untersucht, wie Hunde- und Katzenhalter
Industrielle Viehzucht gefährdet Klimaziele, wie bedeutsame internationale Studie zeigt
LONDON, UK / ACCESS Newswire / 11. November 2025 / Eine neue Studie in Animals zeigte auf, dass die industrielle Viehzucht eine der mächtigsten – und dennoch beharrlich vernachlässigten –
Climate Goals Threatened by Industrialised Animal Farming, Reveals Key International Study
LONDON, UK / ACCESS Newswire / November 11, 2025 / A new study in Animals highlights that industrialized animal farming is one of the most powerful - yet persistently neglected - forces
Pflanzliche Nahrung für Hundebabies: Neue Studie belegt enormen Umweltnutzen von pflanzlichem Hundefutter im Vereinigten Königreich
LONDON, UK / ACCESS Newswire / 25. September 2025 / Eine neue Ökobilanz von 31 Trockenfutterprodukten für Hunde im Vereinigten Königreich zeigt, dass pflanzliche Ernährung in allen wichtigen
Plant-Powered Pups: New Study Shows Dramatic Environmental Gains From Plant-Based Dog Food in the UK
LONDON, UK / ACCESS Newswire / September 25, 2025 / A new life cycle assessment of 31 dry dog foods in the UK reveals that plant-based diets consistently outperform meat-based alternatives
Die Ernährung von Haustieren trägt still und leise zum Klimawandel bei - aber es gibt eine einfache Lösung
LONDON, VEREINIGTES KÖNIGREICH / ACCESS Newswire / 21. Mai 2025 / Mit dem Füttern Ihres Hundes oder Ihrer Katze könnten Sie dem Planeten mehr schaden, als Sie sich vorstellen.
Eine neue Stu
Pet Diets Are Quietly Contributing to Climate Change - but There's a Simple Fix
LONDON, UNITED KINGDOM / ACCESS Newswire / May 21, 2025 / Feeding your dog or cat might be doing more damage to the planet than you think.
A new study has revealed that conventional